16 Nutlin-3 Interaction Tips

Both of these patients were in the oxycodone 0.2?mg.kg?1 group. Patients�� characteristics are shown in Table?2. In the saline group, there was no significant change in minute volume (p?=?0.714) from baseline and hence no naloxone was given to the patients in that group. The average time at which naloxone was administered within each of the active groups was calculated as an indicator of the onset of respiratory depression, as set out in the study criteria. At that time point the mean minute volume in each of the groups was calculated. Table?3 shows the number of patients in each group who received http://www.selleckchem.com/products/ABT-737.html naloxone and the number of doses given. Table?4 shows the percentage change in minute volume from baseline in all groups, and the time at which naloxone was first administered in active groups. The minute volume in the morphine and oxycodone groups decreased significantly from baseline (Table?4). There was also a significant difference in the fall in minute volume between the three oxycodone groups (p?=?0.0007). In the patients who received naloxone, there was a significant improvement in minute volume from the pre-naloxone values (p? http://www.selleckchem.com/products/Nutlin-3.html equivalence rate after parenteral administration. Oxycodone may produce a dose dependent decrease in respiration, although the exact nature and comparison with morphine remain to be substantiated using randomised controlled trials [8, 9, 16, 25]. The primary objective of this pilot study was to characterise the respiratory profile of oxycodone in spontaneously breathing anaesthetised patients and compare it with morphine when administered intravenously. The additive effect of opioids and volatile maintained general anaesthesia on spontaneous ventilation facilitates a sensitive model http://www.selleck.cn/products/Methazolastone.html that has been used in previous studies evaluating the respiratory effects of opioids [24, 26]. The equivalent dose when converting between parenteral morphine and oxycodone is variable, with a suggested ratio of 0.65�C1.0, although some reports have quoted an even higher conversion ratio of 1.5 when converting the two drugs. Three doses of oxycodone were chosen (0.05, 0.1 and 0.2?mg.kg?1) in our study, reflecting doses that are a 0.5, 1.0 and 1.5 conversion ratio respectively. The different doses of oxycodone were chosen on the assumption that the middle dose may be equi-analgesic to morphine, and the other two were half and double respectively. All three doses of oxycodone used in the study produced dose dependent, statistically significant, respiratory depression.